138 related articles for article (PubMed ID: 12757267)
1. Will reference pricing address the health cost conundrum?
Iglehart JK
Health Aff (Millwood); 2003; 22(3):7-8. PubMed ID: 12757267
[No Abstract] [Full Text] [Related]
2. Reference pricing for drugs: is it compatible with U.S. health care?
Kanavos P; Reinhardt U
Health Aff (Millwood); 2003; 22(3):16-30. PubMed ID: 12757268
[TBL] [Abstract][Full Text] [Related]
3. Prescription drug pricing: the consumer perspective.
Searing A
N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625
[No Abstract] [Full Text] [Related]
4. If foreign drug prices go up, will U.S. prices come down?
Med Health; 2003 Dec; 57(45):2-4. PubMed ID: 14723168
[No Abstract] [Full Text] [Related]
5. Drug insurance utilization management policies and "reference pricing": an illustrated commentary on the article by Vittorio Maio and colleagues.
Maclure M
Milbank Q; 2005; 83(1):131-47. PubMed ID: 15787956
[No Abstract] [Full Text] [Related]
6. Affordable prescription drugs--state and federal action.
Ohio Nurses Rev; 2003 Aug; 78(7):4. PubMed ID: 15134064
[No Abstract] [Full Text] [Related]
7. The high price of aging.
Charatan FB
West J Med; 2000 Jun; 172(6):363-4. PubMed ID: 10854373
[No Abstract] [Full Text] [Related]
8. Bitter pills.
Carpenter D
Hosp Health Netw; 2000 Aug; 74(8):48-52. PubMed ID: 10983224
[No Abstract] [Full Text] [Related]
9. The challenge of expanding health benefits for the aged.
Elwood TW
J Allied Health; 2000; 29(4):189-95. PubMed ID: 11147184
[No Abstract] [Full Text] [Related]
10. Medicare and the politics of prescription drug pricing.
Oberlander J
N C Med J; 2003; 64(6):303-4. PubMed ID: 14983626
[No Abstract] [Full Text] [Related]
11. Higher profile puts them in the crosshairs.
Calandra R
Manag Care; 2016 Dec; 25(12):28-29. PubMed ID: 28121556
[TBL] [Abstract][Full Text] [Related]
12. Dilemmas in regulation of the market for pharmaceuticals.
Maynard A; Bloor K
Health Aff (Millwood); 2003; 22(3):31-41. PubMed ID: 12757269
[TBL] [Abstract][Full Text] [Related]
13. Government commitment and regulation of prescription drugs.
Frank RG
Health Aff (Millwood); 2003; 22(3):46-8. PubMed ID: 12757271
[TBL] [Abstract][Full Text] [Related]
14. Controlling spending for prescription drugs.
Altman SH; Parks-Thomas C
N Engl J Med; 2002 Mar; 346(11):855-6. PubMed ID: 11893800
[No Abstract] [Full Text] [Related]
15. Medicare should bargain for lower drug prices, study says.
Med Health; 2005 Oct; 59(36):1, 3, 7. PubMed ID: 16240494
[No Abstract] [Full Text] [Related]
16. An Rx for reform: a Medicare prescription drug benefit.
Rak J
Health Matrix Clevel; 2002; 12(2):449-505. PubMed ID: 12430363
[No Abstract] [Full Text] [Related]
17. Medicare prescription drugs and reform: what the new law will mean to gastroenterologists and their patients.
Fise T
Am J Gastroenterol; 2004 May; 99(5):775-6. PubMed ID: 15128335
[No Abstract] [Full Text] [Related]
18. Chronic conditions and disabilities: trends and issues for private drug plans.
Boccuti C; Moon M; Dowling K
Policy Brief Commonw Fund; 2003 Oct; (680):1-10. PubMed ID: 14562797
[No Abstract] [Full Text] [Related]
19. Estimating the cost of a Medicare outpatient prescription drug benefit.
Waldo DR
Health Care Financ Rev; 1994; 15(3):103-12. PubMed ID: 10172143
[TBL] [Abstract][Full Text] [Related]
20. Pharmacy discount card programs: catching up with the health markets.
Edwards D
Empl Benefits J; 2002 Sep; 27(3):42-3. PubMed ID: 12219563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
